LAS VEGAS, NV, April 17, 2018 -- Ameritek Ventures (OTC: ATVK) (“the Company”), today announced that it has secured access to $1,050,000 in funding through a private lender. These funds are available over a 12-month period, in multiple tranches.
Ameritek is also in advanced negotiations towards securing permanent funding that will enable the execution of its strategic plan, including the assembly of a manufacturing, research and technology center in Roanoke, VA. The Company has completed concept design work and anticipates beginning equipment fabrication and assembly in the third quarter of 2018. Management anticipates launching the production of optical fiber preforms in early 2019.
“We are pleased to have secured access to this funding, as it represents a key step towards completing a permanent financing transaction that will enable Ameritek to advance its manufacturing and commercial objectives," stated Clinton Stokes III, Ameritek’s Chief Executive Officer. "As part of our ongoing negotiations, we see an opportunity to establish licensing agreements across multiple global jurisdictions that would provide capital from licensing fees that would fast-track the build-out and expand the manufacturing capacity in our Virginia facility. This would enable Ameritek to meet robust market demand for high-quality fiber optic preforms to the global telecommunications industry.”
About Ameritek Ventures
Ameritek Ventures is a manufacturer of proprietary machinery that is used to produce optical fiber preforms. These preforms are then used to produce commercial grade optical fiber. Once produced, this optical fiber is fabricated into fiber optic cable which serves as the backbone of the multi-billion dollar telecommunication industry.
The market demand for preforms and optical fiber has experienced rapid growth in the wireless, cable television, internet and high-speed data transmission industries. The Company's equipment, processes and managed system deployments will provide the market with the highest quality preforms used to manufacture fiber optic cable and will support significant growth worldwide.
Forward-Looking Statements
Included in this release are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Although the company believes that the expectations reflected in such forward-looking statements are reasonable, it can give no assurance that such expectations reflected in such forward-looking statements will prove to have been correct. The company's actual results could differ materially from those anticipated in the forward-looking statements.
Investor Contact: Steve Silver / Phil Carlson KCSA Strategic Communications 212-896-1220 / 212-896-1233 [email protected] / [email protected]


ANZ Shares Hit Record High After Strong Q1 Profit and Cost-Cutting Gains
U.S. Judge Allows Jeffrey Epstein Sex Trafficking Lawsuit Against Bank of America to Proceed
Paramount Skydance Appoints Rene Augustine as SVP of Global Public Policy Amid Warner Bros Takeover Battle
AbbVie Sues HHS Over Medicare Price Controls on Botox Under Inflation Reduction Act
Bank of America CEO Brian Moynihan’s 2025 Compensation Rises 17% to $41 Million Amid Strong Profit Growth
U.S. Commerce Department Reaches $252 Million Settlement With Applied Materials Over China Exports
Grok AI Market Share Surges as xAI Faces Scrutiny Over Image Generation Controversy
Russia Moves to Fully Block WhatsApp as Kremlin Pushes State-Backed MAX App
Spirit Airlines Seeks Court Approval to Auction 20 Airbus A320/A321 Aircraft Amid Bankruptcy
Boeing Reports Major Supply Chain Quality Improvements After Spirit AeroSystems Deal
Michael Kors Marks 45 Years at New York Fashion Week with Fall/Winter Collection Showcase
Xiaomi EV Deliveries Surpass 600,000 Units as SU7 and YU7 Drive Strong Growth
Instagram CEO Defends Platform in Youth Mental Health Lawsuit Over Social Media Addiction Claims
GE Aerospace Expands Singapore Engine Repair Hub with Automation and AI to Tackle Aviation Bottlenecks
How Marco Pharma International Preserves German Homeopathic Traditions in America
Sachem Head Boosts Warner Bros. Discovery Stake Amid Netflix Deal and Paramount Bid
Novartis’ Vanrafia Shows Strong Phase 3 Results in IgA Nephropathy, Paving Way for Full Approval 



